Literature DB >> 12485550

Incontinence Quality of Life Instrument in a survey of primary care physicians.

Murray M Finkelstein1, Jennifer Skelly, Janusz Kaczorowski, Graham Swanson.   

Abstract

OBJECTIVE: To assess the performance of the Incontinence Quality of Life (I-QOL) Instrument in measuring the impact of urinary incontinence on the quality of life of family medicine patients. STUDY
DESIGN: Postal survey. Multiple imputations of missing answers. Linear regression analysis of I-QOL predictors. Comparison by receiver operating characteristic of the I-QOL and the Short Form 12 (SF-12). POPULATION: Women 45 years or older attending either of 2 family medicine clinics. Response rate was 605 (61%) of 992. OUTCOMES MEASURED: Prevalence of stress, urge, and mixed incontinence. Scores on the I-QOL and SF-12 instruments.
RESULTS: Of the 605 respondents, 310 (51%) reported urinary incontinence in the month before the survey. One or more items were missing on 19% of the I-QOL scales and scores were imputed. The relation between I-QOL and the number of leakage episodes was nonlinear. I-QOL scores decreased with the number of episodes, the amount of leakage, and poorer general health. There was no association between the I-QOL and age, education, or type of incontinence. The I-QOL was more sensitive than the SF-12 to the statement, "urinary incontinence is a problem."
CONCLUSIONS: The I-QOL is a useful instrument for the investigation of incontinence-related quality of life in the community setting.

Entities:  

Mesh:

Year:  2002        PMID: 12485550

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  9 in total

1.  OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales.

Authors:  Nick Freemantle; Kristin Khalaf; Clara Loveman; Sanja Stanisic; Dmitry Gultyaev; Johanna Lister; Marcus Drake
Journal:  Eur J Health Econ       Date:  2015-10-19

2.  [Different attitudes towards hypertension and urinary tract incontinence in elderly individuals participating in a health promotion project].

Authors:  Katharina Pils; Friederike Neumann
Journal:  Wien Med Wochenschr       Date:  2006-03

3.  Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

Authors:  Dyfrig A Hughes; Dominique Dubois
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 4.  Dilemmas in the management of female stress incontinence: the role of pelvic floor muscle training.

Authors:  Hatzimouratidis Konstantinos; Konstantinidou Eleni; Hatzichristou Dimitrios
Journal:  Int Urol Nephrol       Date:  2006-11-29       Impact factor: 2.370

5.  Increasing Discussion Rates of Incontinence in Primary Care: A Randomized Controlled Trial.

Authors:  Sophia Miryam Schüssler-Fiorenza Rose; Ronald E Gangnon; Betty Chewning; Arnold Wald
Journal:  J Womens Health (Larchmt)       Date:  2015-11       Impact factor: 2.681

6.  Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms.

Authors:  Edmond P H Choi; Cindy L K Lam; Weng-Yee Chin
Journal:  Health Qual Life Outcomes       Date:  2014-01-02       Impact factor: 3.186

7.  Severity of Lower Urinary Tract Symptoms among Middle Aged and Elderly Nigerian Men: Impact on Quality of Life.

Authors:  Patrick Temi Adegun; Philip Babatunde Adebayo; Peter Olufemi Areo
Journal:  Adv Urol       Date:  2016-06-19

8.  Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module.

Authors:  Jesús Cuervo; Nacho Castejón; Kristin M Khalaf; Catherine Waweru; Denise Globe; Donald L Patrick
Journal:  Health Qual Life Outcomes       Date:  2014-10-08       Impact factor: 3.186

9.  Mapping of incontinence quality of life (I-QOL) scores to assessment of quality of life 8D (AQoL-8D) utilities in patients with idiopathic overactive bladder.

Authors:  Gang Chen; Jonathan T Tan; Kwong Ng; Angelo Iezzi; Jeffrey Richardson
Journal:  Health Qual Life Outcomes       Date:  2014-08-30       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.